Valuation: Abbott Laboratories

Market Cap 166B 145B 134B 124B 235B 15,874B 240B 1,614B 627B 7,768B 623B 609B 26,967B P/E 2026 *
23.5x
P/E 2027 * 20.1x
Enterprise Value 177B 156B 144B 133B 252B 16,994B 257B 1,728B 671B 8,316B 666B 652B 28,868B EV / Sales 2026 *
3.53x
EV / Sales 2027 * 3.19x
Free-Float
86.73%
Yield 2026 *
2.68%
Yield 2027 * 2.85%
1 day-0.69%
1 week+3.25%
Current month+4.89%
1 month+5.17%
3 months-8.09%
6 months-24.57%
Current year-24.03%
1 week 92.99
Extreme 92.99
98.14
1 month 87.07
Extreme 87.0706
98.14
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
137.49
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 37.38
Extreme 37.38
142.6
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Date Insider Type Main position Quantity % Market Cap.
06-30Free

Director

363 0.0000%
06-30Tax

EXECUTIVE VICE PRESIDENT

-269 0.0000%
06-30Free

Director

432 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-0.69%+3.25%-28.63%-10.50% 166B
-2.17%+3.55%-7.42%-4.52% 105B
+1.67%+7.33%+3.87%+62.20% 60.23B
+3.64%-3.17%+43.86%+54.63% 49.17B
-3.67%-1.53%-13.78%-41.40% 41.49B
-6.30%-3.43% - - 34.08B
+0.67%+7.55%-11.58%-41.55% 28.58B
-0.67%-3.10%+60.41%-4.82% 24.99B
-2.15%+0.59%-10.20%+3.70% 20.64B
-2.74%-1.32%-9.92%-3.84% 20.42B
Average -1.24%+1.27%+2.96%+1.54% 55.04B
Weighted average by Cap. -0.96%+1.99%-5.70%+2.30%

Financials

2026 *2027 *
Net sales 50.26B 44.08B 40.7B 37.61B 71.28B 4,812B 72.71B 489B 190B 2,355B 189B 185B 8,175B 54.75B 48.02B 44.33B 40.97B 77.65B 5,242B 79.2B 533B 207B 2,565B 206B 201B 8,905B
Net income 7.02B 6.16B 5.68B 5.25B 9.95B 672B 10.15B 68.32B 26.54B 329B 26.35B 25.78B 1,142B 8.39B 7.36B 6.79B 6.28B 11.9B 803B 12.14B 81.67B 31.73B 393B 31.5B 30.81B 1,365B
Net Debt 11.69B 10.25B 9.47B 8.75B 16.58B 1,119B 16.91B 114B 44.21B 548B 43.9B 42.93B 1,901B 8.86B 7.77B 7.17B 6.63B 12.56B 848B 12.81B 86.22B 33.5B 415B 33.26B 32.53B 1,441B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
08/07/26 $95.18 -0.69% 10,102,295
07/07/26 $95.84 +0.22% 10,262,177
06/07/26 $95.63 +0.24% 15,257,037
02/07/26 $95.40 +3.49% 10,644,582
01/07/26 $92.18 +1.59% 13,935,849
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
95.18USD
Average target price
116.40USD
Spread / Average Target
+22.29%

Quarterly revenue - Rate of surprise